Literature DB >> 9673341

Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model.

G S Nanda1, F X Sun, G A Hofmann, R M Hoffman, S B Dev.   

Abstract

BACKGROUND: A new method of cancer treatment called electroporation therapy (EPT) which uses pulsed electric fields in combination with a chemotherapeutic agent is being developed to treat human pancreatic tumors. Such a combination has been found to increase the cytotoxic effect of the drug to tumor cells.
METHODS: Human pancreatic tumors (Pan-4-JCK) were implanted subcutaneously onto nude mice. The animals were treated with EPT using bleomycin, mitomycin C or carboplatin as a single agent, and their effect on tumor growth was monitored over a period of 89 days.
RESULTS: The tumors treated with either the drug or pulse alone showed increased tumor growth. However, tumors treated with EPT using any one of the three drugs showed significant to complete regression of tumors. Among the three drugs used, the order of efficacy was: bleomycin >> mitomycin C > carboplatin.
CONCLUSIONS: These results are sufficient to warrant limited clinical trials of EPT for pancreatic cancers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673341

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene.

Authors:  T Goto; T Nishi; T Tamura; S B Dev; H Takeshima; M Kochi; K Yoshizato; J Kuratsu; T Sakata; G A Hofmann; Y Ushio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Dynamics of bleomycin interaction with a strongly bound hairpin DNA substrate, and implications for cleavage of the bound DNA.

Authors:  Trevor C Bozeman; Rupesh Nanjunda; Chenhong Tang; Yang Liu; Zachary J Segerman; Paul A Zaleski; W David Wilson; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2012-10-22       Impact factor: 15.419

4.  Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation.

Authors:  Roberto Girelli; Simona Prejanò; Ivana Cataldo; Vincenzo Corbo; Lucia Martini; Aldo Scarpa; Bassi Claudio
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

5.  Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma.

Authors:  Derek Lamont West; Sarah B White; Zhouli Zhang; Andrew C Larson; Reed A Omary
Journal:  Int J Nanomedicine       Date:  2014-09-01

Review 6.  Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies.

Authors:  Sabrina Bimonte; Maddalena Leongito; Vincenza Granata; Antonio Barbieri; Vitale Del Vecchio; Michela Falco; Aurelio Nasto; Vittorio Albino; Mauro Piccirillo; Raffaele Palaia; Alfonso Amore; Raimondo di Giacomo; Secondo Lastoria; Sergio Venanzio Setola; Roberta Fusco; Antonella Petrillo; Francesco Izzo
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.